drugset / Trial / NCT01157936
Hyperuricemia on Hypertension and Metabolic Syndrome
Phase 2
Completed
40 enrolled
Instituto Nacional de Cardiologia Ignacio Chavez
National Council of Science and Technology, Mexico · collab
RandomizedCrossoverQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the influence of hyperuricemia treatment compared with placebo on participants with high risk of hypertension and metabolic syndrome.
Timeline
- Start
- 2010-07
- Primary completion
- 2011-02
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Allopurinol | Small molecule | — | — |